Ventilator – associated pneumonia (VAP) Source: Eur Respir J 2004; 24: Suppl. 48, 547s Year: 2004
Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP) Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track Year: 2005
The role of serum inflammatory markers in the detection of ventilation associated pneumonia (VAP) Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009
Type of acute respiratory failure and development of ventilator-associated pneumonia (VAP) Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
NIV in community-acquired pneumonia Source: Annual Congress 2005 - Noninvasive ventilation (NIV) in hypoxaemic acute respiratory failure (ARF) Year: 2005
Ventilator-associated pneumonia (VAP) – Early and late-onset differences Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
Ventilator associated pneumonia, aspiration and sepsis Source: International Consensus Conference in Intensive Care Medicine 2005 Year: 2005
Rapid quantification of bacteria associated to ventilator associated pneumonia in endotracheal aspirate specimens Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
Lung physiology and inflammatory markers in treated and untreated ventilator associated pneumonia (VAP), lessons learned from a porcine model Source: Eur Respir J 2006; 28: Suppl. 50, 785s Year: 2006
Non-invasive ventilation (NIV) in hospital-acquired pneumonia (HAP) of non-ICU COPD patients Source: Annual Congress 2008 - Noninvasive mechanical ventilation in the acute setting Year: 2008
Non-invasive ventilation (NIV) in community-acquired pneumonia CAP) and severe acute respiratory failure (ARF): Effectiveness and risk factors for failure and mortality Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure Year: 2011
De-escalation therapy in ventilator acquired pneumonia (VAP) Source: Annual Congress 2011 - Pulmonary infections and sepsis Year: 2011
Implications of identifying the pathogen in ventilator-associated pneumonia (VAP) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007
Thyroid function in community-acquired pneumonia (CAP) patients: Pattern, relationship with severity and outcomes, need for invasive mechanical ventilation and vasopressor support Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010
Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007
Defining stability in pneumonia and the non-responding pneumonia Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005
Lung vessel thrombosis like the reason of mortality at severe community-acquired pneumonia (CAP) of viral and bacterial etiology - autopsy data Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018
Ventilator associated pneumonia: the role of bronchoscopy to investigate and to diagnose lung infection Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009